Cerner stock hit an all-time high yesterday with shares rising as high as $94.80 before an afternoon sell-off brought them down to earth. The company's good fortune led to renewed rumors of interest on the part of a major player--possibly Oracle. The increased interest appears to have been triggered at least in part by a delayed reaction to the release of the company's third-quarter results and media reports which indicate plans to hire more workers.
- see this article from the Kansas City Star
ALSO: An agreement between Cerner and Correlagen Diagnostics will allow users of Cerner's Millennium software to order and access genetic tests. Supporters have been talking about the miracles that could happen when electronic medical records are combined with genomics. This is a start. Release